| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| Company: Vesselon |
| Recipient: You |
| Company: nuvalent |
| Recipient: You |
| Company: En Fuego Therapeutics |
| Recipient: You |
| Company: Vertex |
| Recipient: You |
| Company: Merus |
| Recipient: You |
| Company: rvmd |
| Recipient: You |
|
| Honoraria |
| No Relationships to Disclose |
|
|
| Consulting or Advisory Role |
| Company: AstraZeneca |
| Recipient: You |
| Company: EMD Serono |
| Recipient: You |
| Company: Nanobiotix |
| Recipient: You |
| Company: BeiGene |
| Recipient: You |
| Company: PDS Biotechnology |
| Recipient: You |
| Company: Amgen |
| Recipient: You |
| Company: Pharmacosmos |
| Recipient: You |
| Company: GSK |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Loxo/Lilly |
| Recipient: Your Institution |
| Company: PDS Biotechnology |
| Recipient: Your Institution |
| Company: Genmab |
| Recipient: Your Institution |
| Company: Iovance Biotherapeutics |
| Recipient: Your Institution |
| Company: Nurix |
| Recipient: Your Institution |
| Company: TScan Therapeutics |
| Recipient: Your Institution |
| Company: Inspirna |
| Recipient: Your Institution |
| Company: Janux Therapeutics |
| Recipient: Your Institution |
| Company: Pharmacosmos |
| Recipient: Your Institution |
| Company: BMS |
| Recipient: Your Institution |
| Company: Summit Therapeutics |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| not answered |
|
|
| (OPTIONAL) Open Payments Link |
| not answered |
|
|